GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NFL Biosciences SA (XPAR:ALNFL) » Definitions » EV-to-Revenue

NFL Biosciences (XPAR:ALNFL) EV-to-Revenue : (As of Jun. 03, 2025)


View and export this data going back to 2021. Start your Free Trial

What is NFL Biosciences EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, NFL Biosciences's enterprise value is €13.13 Mil. NFL Biosciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil. Therefore, NFL Biosciences's EV-to-Revenue for today is .

The historical rank and industry rank for NFL Biosciences's EV-to-Revenue or its related term are showing as below:

XPAR:ALNFL's EV-to-Revenue is not ranked *
in the Biotechnology industry.
Industry Median: 7.39
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-03), NFL Biosciences's stock price is €1.20. NFL Biosciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00. Therefore, NFL Biosciences's PS Ratio for today is .


NFL Biosciences EV-to-Revenue Historical Data

The historical data trend for NFL Biosciences's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NFL Biosciences EV-to-Revenue Chart

NFL Biosciences Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
Get a 7-Day Free Trial - - - - -

NFL Biosciences Semi-Annual Data
Dec18 Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of NFL Biosciences's EV-to-Revenue

For the Biotechnology subindustry, NFL Biosciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NFL Biosciences's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NFL Biosciences's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where NFL Biosciences's EV-to-Revenue falls into.


;
;

NFL Biosciences EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

NFL Biosciences's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=13.134/0
=

NFL Biosciences's current Enterprise Value is €13.13 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. NFL Biosciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NFL Biosciences  (XPAR:ALNFL) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

NFL Biosciences's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=1.20/0
=

NFL Biosciences's share price for today is €1.20.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2024 was €0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NFL Biosciences EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of NFL Biosciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


NFL Biosciences Business Description

Traded in Other Exchanges
Address
199 rue Helene Boucher, Castelnau-le-Lez, FRA, 34170
NFL Biosciences SA specializes in the research and development of medicines to combat tobacco addiction that use botanical and pharmaceutical agents. NFL-101 is company's core product, targeting smoking addiction. It is a clinically developed, botanical drug that contains an insignificant amount of nicotine and is composed of well characterized, natural tobacco leaf proteins.

NFL Biosciences Headlines

No Headlines